Univariate analysis Univariate analysis Univariate analysis Univariate analysis Univariate analysis Multivariate analysis Multivariate analysis Multivariate analysis Multivariate analysis Multivariate analysis
CSS OS OS CSS CSS OS OS
Characteristics HR(95% CI) P value HR(95% CI) P value HR(95% CI) P value HR(95% CI) P value
Sex 0.023 <0.001
Male Reference Reference Reference Reference
Female 0.89(0.81-0.98) 0.023 0.86(0.79-0.93) < 0.001 0.89(0.81-0.98) 0.023 0.86(0.79-0.93) <0.001
Race 0.777 <0.001
White Reference Reference Reference Reference
Black 1.34(1.12-1.61) 0.001 1.07(0.88-1.3) 0.517 1.34(1.12-1.61) 0.001 1.07(0.88-1.3) 0.517
Other 0.94(0.8-1.11) 0.489 1.28(1.12-1.45) < 0.001 0.94(0.8-1.11) 0.489 1.28(1.12-1.45) <0.001
Marital status <0.001 0.005
Single Reference Reference Reference Reference
Married 0.74(0.62-0.87) < 0.001 0.93(0.8-1.08) 0.343 0.74(0.62-0.87) <0.001 0.93(0.8-1.08) 0.343
Divorced 0.87(0.69-1.1) 0.243 1.03(0.84-1.27) 0.752 0.87(0.69-1.1) 0.243 1.03(0.84-1.27) 0.752
Other 1.05(0.88-1.24) 0.607 0.8(0.68-0.95) 0.01 1.05(0.88-1.24) 0.607 0.8(0.68-0.95) 0.01
Grade <0.001 <0.001
I Reference Reference Reference Reference
II 1.34(1.1-1.63) 0.004 0.8(0.7-0.92) 0.001 1.34(1.1-1.63) 0.004 0.8(0.7-0.92) 0.001
III 2.36(1.89-2.94) <0.001 0.58(0.47-0.7) < 0.001 2.36(1.89-2.94) <0.001 0.58(0.47-0.7) <0.001
IV 3.23(2.22-4.7) <0.001 0.53(0.3-0.96) 0.034 3.23(2.22-4.7) <0.001 0.53(0.3-0.96) 0.034
T stage <0.001 0.072
T1 Reference Reference Reference Reference
T2 1.71(1.44-2.03) <0.001 0.81(0.73-0.9) < 0.001 1.71(1.44-2.03) <0.001 0.81(0.73-0.9) <0.001
T3 3.68(3.14-4.31) <0.001 0.85(0.77-0.95) 0.004 3.68(3.14-4.31) <0.001 0.85(0.77-0.95) 0.004
T4 7.53(6.13-9.26) <0.001 1.19(0.93-1.54) 0.172 7.53(6.13-9.26) <0.001 1.19(0.93-1.54) 0.172
N stage <0.001 0.61
N0 Reference Reference Reference Reference
N1 2.3(2.05-2.58) <0.001 1.06(0.93-1.2) 0.36 2.3(2.05-2.58) <0.001 1.06(0.93-1.2) 0.36
N2 3.82(3.35-4.37) <0.001 0.87(0.71-1.07) 0.195 3.82(3.35-4.37) <0.001 0.87(0.71-1.07) 0.195
TNM Stage <0.001 0.708
Reference Reference Reference Reference
2.42(2.14-2.74) <0.001 0.95(0.86-1.06) 0.019 2.42(2.14-2.74) <0.001 0.95(0.86-1.06) 0.384
3.92(3.49-4.41) <0.001 0.99(0.88-1.11) <0.001 3.92(3.49-4.41) <0.001 0.99(0.88-1.11) 0.899
CEA <0.001 0.703
Positive Reference Reference Reference Reference
Negative 0.52(0.47-0.57) < 0.001 1.02(0.93-1.13) 0.659 0.52(0.47-0.57) <0.001 1.02(0.93-1.13) 0.659
Borderline 1.17(0.72-1.89) 0.525 0.93(0.48-1.8) 0.831 1.17(0.72-1.89) 0.525 0.93(0.48-1.8) 0.831
Tumor size <0.001 <0.001
<3 Reference Reference Reference Reference
3-5 1.56(1.38-1.76) <0.001 0.85(0.77-0.94) 0.001 1.56(1.38-1.76) <0.001 0.85(0.77-0.94) 0.001
5-7 2.2(1.92-2.52) <0.001 0.75(0.66-0.86) < 0.001 2.2(1.92-2.52) <0.001 0.75(0.66-0.86) <0.001
≥7 2.56(2.17-3.01) <0.001 0.72(0.6-0.87) < 0.001 2.56(2.17-3.01) <0.001 0.72(0.6-0.87) <0.001
Months.from.diagnosis.to.treatment 1.01(0.97-1.05) 0.597 1.14(1.11-1.17) <0.001 1.01(0.97-1.05) 0.597 1.14(1.11-1.17) <0.001
Cherapy <0.001 <0.001
Surgery Reference Reference Reference Reference
Combined 1.52(1.36-1.69) < 0.001 1.21(1.09-1.35) <0.001 1.52(1.36-1.69) <0.001 1.21(1.09-1.35) <0.001